| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |